newly discovered Bundibugyo ebolavirus has been proposed as a 5th species. So far, no cross-neutralization among EBOV species has been described, aggravating progress toward cross-species protective vaccines. With the use of recombinant vesicular stomatitis virus (rVSV)–based vaccines, guinea pigs could be protected against Zaire ebolavirus (ZEBOV) infection only when immunized with a vector expressing the homologous, but not a heterologous, EBOV glycoprotein (GP). However, infection of guinea pigs with nonadapted wild-type strains of the different species resulted in full protection of all animals against subsequent challenge with guinea pig–adapted ZEBOV, showing that cross-species protection is possible. New vectors were generated that c...
Background. Outbreaks of filoviral hemorrhagic fever occur sporadically and unpredictably across wid...
The current unprecedented outbreak of Ebola virus (EBOV) disease in West Africa has demonstrated the...
Summary: Previous efforts to identify cross-neutralizing antibodies to the receptor-binding site (RB...
newly discovered Bundibugyo ebolavirus has been proposed as a 5th species. So far, no cross-neutrali...
Previously, recombinant vesicular stomatitis virus (rVSV) pseudotypes expressing Ebolavirus glycopro...
Ebola virus (EBOV), a member of the Filoviridae that can cause severe hemorrhagic fever in humans an...
The filoviruses Ebola virus (EBOV) and Marburg virus (MARV) cause severe hemorrhagic fever in humans...
Ebola virus (EBOV) causes severe and often fatal hemorrhagic fever in humans and nonhuman primates (...
Ebola viruses are highly pathogenic viruses that cause outbreaks of hemorrhagic fever in humans and ...
SummaryPrevious efforts to identify cross-neutralizing antibodies to the receptor-binding site (RBS)...
Pre- or postexposure treatments against the filoviral hemorrhagic fevers are currently not available...
Ebola virus disease is a deadly infection which occurs in sporadic outbreaks. Several vaccine candid...
International audienceThe Ebola and Marburg viruses (from the filovirus family) induce deadly hemorr...
Marburg virus (MARV) is a negative-sense, single-stranded RNA virus that belongs to the Filoviridae ...
Background: Human outbreaks of Ebola virus (EBOV) are a serious human health concern in Central Afri...
Background. Outbreaks of filoviral hemorrhagic fever occur sporadically and unpredictably across wid...
The current unprecedented outbreak of Ebola virus (EBOV) disease in West Africa has demonstrated the...
Summary: Previous efforts to identify cross-neutralizing antibodies to the receptor-binding site (RB...
newly discovered Bundibugyo ebolavirus has been proposed as a 5th species. So far, no cross-neutrali...
Previously, recombinant vesicular stomatitis virus (rVSV) pseudotypes expressing Ebolavirus glycopro...
Ebola virus (EBOV), a member of the Filoviridae that can cause severe hemorrhagic fever in humans an...
The filoviruses Ebola virus (EBOV) and Marburg virus (MARV) cause severe hemorrhagic fever in humans...
Ebola virus (EBOV) causes severe and often fatal hemorrhagic fever in humans and nonhuman primates (...
Ebola viruses are highly pathogenic viruses that cause outbreaks of hemorrhagic fever in humans and ...
SummaryPrevious efforts to identify cross-neutralizing antibodies to the receptor-binding site (RBS)...
Pre- or postexposure treatments against the filoviral hemorrhagic fevers are currently not available...
Ebola virus disease is a deadly infection which occurs in sporadic outbreaks. Several vaccine candid...
International audienceThe Ebola and Marburg viruses (from the filovirus family) induce deadly hemorr...
Marburg virus (MARV) is a negative-sense, single-stranded RNA virus that belongs to the Filoviridae ...
Background: Human outbreaks of Ebola virus (EBOV) are a serious human health concern in Central Afri...
Background. Outbreaks of filoviral hemorrhagic fever occur sporadically and unpredictably across wid...
The current unprecedented outbreak of Ebola virus (EBOV) disease in West Africa has demonstrated the...
Summary: Previous efforts to identify cross-neutralizing antibodies to the receptor-binding site (RB...